HEREDITARY ANGIOEDEMA TYPE II
Clinical trials for HEREDITARY ANGIOEDEMA TYPE II explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY ANGIOEDEMA TYPE II trials appear
Sign up with your email to follow new studies for HEREDITARY ANGIOEDEMA TYPE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a simple pill shield HAE patients from Procedure-Triggered attacks?
Disease control Not yet recruitingThis trial tests whether the drug sebetralstat can prevent swelling attacks in people with hereditary angioedema (HAE) when taken before a medical procedure. Participants aged 12 and older with HAE type I or II will take sebetralstat just before their scheduled procedure. The mai…
Matched conditions: HEREDITARY ANGIOEDEMA TYPE II
Phase: PHASE4 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Egyptian HAE patients to be studied for better care insights
Knowledge-focused Not yet recruitingThis study will collect information from medical records and routine clinic visits of 100 people in Egypt with hereditary angioedema (HAE) type I or II. The goal is to understand how the condition is diagnosed and managed in current medical practice. No new treatments are being t…
Matched conditions: HEREDITARY ANGIOEDEMA TYPE II
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC